Trestle Biotherapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 14

Trestle Biotherapeutics General Information

Description

Developer of bioengineered therapies designed to address kidney diseases. The company creates functional therapeutic tissue by integrating stem cell biology and bio-fabrication, enabling healthcare providers to reduce reliance on dialysis and deliver improved treatment options for patients with chronic kidney disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9276 Scranton Road
  • San Diego, CA 92121
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 9276 Scranton Road
  • San Diego, CA 92121
  • United States

Trestle Biotherapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trestle Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC 20-Sep-2024 Completed Startup
7. Accelerator/Incubator 12-Jun-2023 Completed Startup
6. Early Stage VC 01-Mar-2022 Completed Startup
5. Accelerator/Incubator 01-Jan-2022 Completed Startup
4. Early Stage VC 01-Dec-2021 Completed Startup
3. Seed Round 01-Apr-2021 Completed Startup
2. Accelerator/Incubator 25-Mar-2021 $125K $125K Completed Startup
1. University Spin-Out 11-Mar-2020 Completed Startup
To view Trestle Biotherapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Trestle Biotherapeutics Patents

Trestle Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12781189-B2 Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof Active 03-Oct-2024
US-20260098246-A1 Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof Active 03-Oct-2024
WO-2026076399-A2 Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof Pending 03-Oct-2024
WO-2026076399-A3 Compositions and processes for engineering ureteric bud kidney tissues and in-vitro compositions thereof Pending 03-Oct-2024
WO-2026076410-A1 Compositions and processes for vascularization of kidney tissues and in-vitro compositions thereof Pending 03-Oct-2024 A61L27/3834
To view Trestle Biotherapeutics’s complete patent history, request access »

Trestle Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trestle Biotherapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
KidneyX Accelerator/Incubator
Axial (San Francisco) Venture Capital Minority
C3 Ventures (VC) Venture Capital Minority
Draper Associates Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 14 investors. Get the full list »

Trestle Biotherapeutics FAQs

  • When was Trestle Biotherapeutics founded?

    Trestle Biotherapeutics was founded in 2020.

  • Where is Trestle Biotherapeutics headquartered?

    Trestle Biotherapeutics is headquartered in San Diego, CA.

  • What is the size of Trestle Biotherapeutics?

    Trestle Biotherapeutics has 6 total employees.

  • What industry is Trestle Biotherapeutics in?

    Trestle Biotherapeutics’s primary industry is Biotechnology.

  • Is Trestle Biotherapeutics a private or public company?

    Trestle Biotherapeutics is a Private company.

  • What is Trestle Biotherapeutics’s current revenue?

    The current revenue for Trestle Biotherapeutics is .

  • How much funding has Trestle Biotherapeutics raised over time?

    Trestle Biotherapeutics has raised $1.12M.

  • Who are Trestle Biotherapeutics’s investors?

    KidneyX, Axial (San Francisco), C3 Ventures (VC), Draper Associates, and are 5 of 14 investors who have invested in Trestle Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process